ArticleFrontiers in immunology2025

Serum visfatin in multiple sclerosis: distinct profiles in healthy controls, naive patients, and treated RRMS.

Saltanat Mert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.